Test a less sedating plan for agitated delirium in cancer
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study looks at whether using certain sleep/behavior medicines (called neuroleptics) with anti-seizure medicines can calm agitation from delirium without needing as much of the usual “neuroleptic” medicines. It may help people with advanced cancer who are confused and very restless or hard to settle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer that cannot be cured (spread, local advancement, or ongoing return).
- A palliative care team has already evaluated you in the hospital.
- You currently have delirium, meaning sudden confusion that meets DSM-5 criteria.
- Your delirium is “agitated” (very restless/upset) or mixed, needing treatment like a rescue medicine or non-medication calming steps (for example, a sitter).
- You are 18 or older, and your clinician agrees it’s okay to enroll you.
- You have an adult family caregiver involved (spouse, adult child, sibling, parent, or close partner).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving melatonin (a natural sleep hormone) can help prevent delirium (sudden confusion) in older adults who are hospitalized. It may help you if you are 65 or older and admitted to the hospital for general medical care.
This study tests if adding a calming medicine called dexmedetomidine to a sleep-promoting routine can help reduce delirium in ICU patients who are awake and on a breathing machine or high-flow oxygen.
This trial tests two medicines, haloperidol and dexmedetomidine, to see which one works better for calming confusion and agitation in ICU patients who have a traumatic brain injury and are on a breathing machine. If you qualify, the study may help your doctors choose the best treatment for you.
This Phase 2 trial tests whether melatonin can reduce delirium, a sudden confusion that can happen in the ICU. If you qualify, you may be given melatonin to see if it improves alertness and comfort during an expected longer ICU stay.
This trial tests whether ramelteon, a sleep medicine, can reduce delirium—a sudden confusion problem—in people in the intensive care unit (ICU). If you qualify, it may help you (or your loved one) stay clearer and more comfortable during ICU treatment.
This trial tests whether the sleep medication lemborexant can help prevent delirium and improve sleep in elderly patients staying in the surgical ICU. If you qualify, you would receive the study drug or a placebo to see if it helps you stay more alert and avoid confusion during your ICU stay.
Hear when a new Delirium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.